BSEM — Biostem Technologies Balance Sheet
0.000.00%
Last trade - 00:00
- $127.07m
- $132.99m
- $4.34m
- 11
- 21
- 86
- 33
2015 December 31st | R2016 December 31st | R2017 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PRESS | ARS | Interim Report | ARS | ARS |
Standards: | — | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.412 | 0.176 | 0.052 | 0.101 | 0.34 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.152 | 0.032 | 0.019 | 0.012 | 0.3 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.785 | 0.316 | 0.231 | 0.851 | 1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.34 | 1.78 | 1.68 | 1.35 | 1.28 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 2.94 | 3.23 | 2.39 | 2.67 | 2.74 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.792 | 2.26 | 1.1 | 6.8 | 6.73 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.29 | 2.25 | 1.57 | 8.47 | 8.3 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1.64 | 0.974 | 0.818 | -5.8 | -5.57 |
Total Liabilities & Shareholders' Equity | 2.94 | 3.23 | 2.39 | 2.67 | 2.74 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |